CVS Health Corp. is expanding drive-through testing sites for COVID-19 to 350 locations in 14 U.S. states with an aim to open 1,000 sites nationwide by the end of May.
A highly anticipated trial pitting New York state against McKesson Corp., Johnson & Johnson, CVS Health Corp. and others for allegedly fueling the opioid epidemic was postponed due to the coronavirus outbreak, according to the court.
CVS Health Corp.’s pharmacy benefit management (PBM) unit is launching a new program under which employers and insurers will be able to offer diabetes drugs, including insulin, at no out-of-pocket costs to their members.
Walgreens Boots Alliance Inc.’s quarterly profit missed Wall Street estimates, hit by lower payments from insurers on drugs sold at the company’s U.S. pharmacies, knocking back the pharmacy store chain’s shares and those of rival CVS Health Corp.
CVS Health Corp. and the drugstore chain’s Omnicare unit were sued by the U.S. government, which accused them of fraudulently billing Medicare and other programs for drugs for older and disabled people without valid prescriptions.
CVS Health Corp. said the company will make it easier for patients with advanced cancer enrolled in some Aetna insurance plans to receive broad genetic gene sequencing tests that can help identify the best drug or treatment for them.
United Parcel Service Inc. Flight Forward drones have flown prescription medications to the front lawn of a private home and to a retirement center, the UPS unit’s first revenue-generating deliveries for drugstore chain CVS Health Corp.
A federal appeals court rejected a bid by eight drug retailers and distributors to disqualify the judge overseeing nationwide opioid litigation after they claimed his rulings, public statements and efforts to encourage settlements created an appearance of bias.
The FDA found “unacceptable levels” of a cancer-causing impurity in limited testing using low-heat method of samples of heartburn medicines such as Zantac containing the ingredient ranitidine.
Eight drug companies urged a federal appeals court to disqualify the judge overseeing nationwide opioid litigation, in a last-ditch effort to avoid having him preside over a landmark trial.